RT Journal Article
SR Electronic
T1 COVID-19 Transmission Dynamics and Effectiveness of Public Health Interventions in New York City during the 2020 Spring Pandemic Wave
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.08.20190710
DO 10.1101/2020.09.08.20190710
A1 Wan Yang
A1 Jaimie Shaff
A1 Jeffrey Shaman
YR 2020
UL http://medrxiv.org/content/early/2020/09/09/2020.09.08.20190710.abstract
AB New York City experienced a large COVID-19 pandemic wave during March – May 2020. We model the transmission dynamics of COVID-19 in the city during the pandemic and estimate the effectiveness of public health interventions (overall and for each major intervention separately) for the entire population and by age group. We estimate that the overall effective reproductive number was 2.99 at the beginning of the pandemic wave and reduced to 0.93 one week after the stay-at-home mandate. Most age groups experienced similar reductions in transmission. Interventions reducing contact rates were associated with a 70.7% (95% CI: 65.0 – 76.4%) reduction of transmission overall and > 50% for all age groups during the pandemic. Face covering was associated with a 6.6% (95% CI: 0.8 – 12.4%) reduction of transmission overall and up to 20% for 65+ year-olds during the first month of implementation. Accounting for the amount of time masks are in use (i.e. mainly outside homes), these findings indicate universal masking could reduce transmission by up to 28-32% when lockdown-like measures are lifted, if the high effectiveness estimated for older adults were achieved for all ages. These estimates are verified by out-of-fit projections and support the need for implementing multiple interventions simultaneously in order to effectively mitigate the spread of COVID-19.Competing Interest StatementJ Shaman and Columbia University disclose partial ownership of SK Analytics. J Shaman discloses consulting for BNI. Other authors have nothing to disclose.Funding StatementThis study was supported by the National Institute of Allergy and Infectious Diseases (AI145883), the National Science Foundation Rapid Response Research Program (RAPID; 2027369), and the NYC DOHMH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was classified as public health surveillance and exempt from ethical review and informed consent by the Institutional Review Boards of both Columbia University and NYC DOHMH.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe COVID-19 case and mortality data used here are permitted via a data use and nondisclosure agreement with the NYC DOHMH. Part of the data are publicly available at https://github.com/nychealth/coronavirus-data. For full access, please contact the NYC DOHMH. https://github.com/nychealth/coronavirus-data